Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids-Reference-Cited by-同舟云学术

Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids

Published:2014-11-27 Issue:6 Volume:54 Page:1050-1055
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Ibrahim Fowzia,Choy Ernest,Gordon Patrick,Doré Caroline J.,Hakim Alan,Kitas George,Isenberg David,Griffiths Bridget,Lecky Bryan,Chakravarty Kuntal,Winer John,Danko Katalin,Cooper Robert G.,White-Alao Beverley,Scott David L.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/54/6/1050/17389657/keu442.pdf

Reference20 articles.

1. Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis;Fries;Arthritis Rheum,1973

2. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis;Dalakas;N Engl J Med,1993

3. Therapeutic approaches in myositis;Aggarwal;Curr Rheumatol Rep,2011

4. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis;Gordon;Cochrane Database Syst Rev,2012

5. Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis;Choy;Ann Rheum Dis,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches;Italian Journal of Dermatology and Venereology;2023-05

2. Clinical trials: General concepts and interpretation;Revista Colombiana de Reumatología (English Edition);2023-04

3. Ensayos clínicos: conceptos generales e interpretación;Revista Colombiana de Reumatología;2023-04

4. Dermatomyositis and juvenile dermatomyositis;Zeitschrift für Rheumatologie;2022-04-29

5. Inflammatory myopathies: shedding light on promising agents and combination therapies in clinical trials;Expert Opinion on Investigational Drugs;2021-11-02